WO2005049066A3 - Proteine impliquee dans le cancer du poumon - Google Patents

Proteine impliquee dans le cancer du poumon Download PDF

Info

Publication number
WO2005049066A3
WO2005049066A3 PCT/GB2004/004847 GB2004004847W WO2005049066A3 WO 2005049066 A3 WO2005049066 A3 WO 2005049066A3 GB 2004004847 W GB2004004847 W GB 2004004847W WO 2005049066 A3 WO2005049066 A3 WO 2005049066A3
Authority
WO
WIPO (PCT)
Prior art keywords
dudulin2
prophylaxis
treatment
lung cancer
modulate
Prior art date
Application number
PCT/GB2004/004847
Other languages
English (en)
Other versions
WO2005049066A2 (fr
Inventor
Jonathan Alexander Terrett
Original Assignee
Celltech R&D Ltd
Jonathan Alexander Terrett
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd, Jonathan Alexander Terrett filed Critical Celltech R&D Ltd
Publication of WO2005049066A2 publication Critical patent/WO2005049066A2/fr
Publication of WO2005049066A3 publication Critical patent/WO2005049066A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne de nouvelles utilisations de la duduline 2 dans le diagnostic, le criblage, le traitement et la prophylaxie du cancer du poumon. L'invention concerne également des compositions comprenant de la duduline 2, en particulier des vaccins et des agents interagissant avec l'expression ou l'activité de la duduline 2 ou modulant l'expression de l'activité de la duduline 2, ou modulant l'expression de l'acide nucléique codant la duduline 2.
PCT/GB2004/004847 2003-11-18 2004-11-16 Proteine impliquee dans le cancer du poumon WO2005049066A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0326834.9 2003-11-18
GBGB0326834.9A GB0326834D0 (en) 2003-11-18 2003-11-18 A protein involved in lung cancer

Publications (2)

Publication Number Publication Date
WO2005049066A2 WO2005049066A2 (fr) 2005-06-02
WO2005049066A3 true WO2005049066A3 (fr) 2005-07-14

Family

ID=29764007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/004847 WO2005049066A2 (fr) 2003-11-18 2004-11-16 Proteine impliquee dans le cancer du poumon

Country Status (2)

Country Link
GB (1) GB0326834D0 (fr)
WO (1) WO2005049066A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053454A2 (fr) * 2000-01-21 2001-07-26 Hyseq, Inc. Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
WO2001072962A2 (fr) * 2000-03-24 2001-10-04 Fahri Saatcioglu Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053454A2 (fr) * 2000-01-21 2001-07-26 Hyseq, Inc. Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
WO2001072962A2 (fr) * 2000-03-24 2001-10-04 Fahri Saatcioglu Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique

Also Published As

Publication number Publication date
GB0326834D0 (en) 2003-12-24
WO2005049066A2 (fr) 2005-06-02

Similar Documents

Publication Publication Date Title
TW200505875A (en) Novel compounds
WO2006020773A3 (fr) Procedes permettant de preparer des plaquettes lyophilisees, compositions contenant lesdites plaquettes lyophilisees, et procedes d'utilisation associes
WO2007011962A3 (fr) Traitement du cancer
WO2003008583A3 (fr) Nouvelles compositions et methodes relatives au cancer
WO2005049593A3 (fr) Promoteurs de l'apoptose contenant n-acylsulfonamide
WO2003083041A3 (fr) Anticorps specifiques au cripto
WO2006133271A3 (fr) Compositions et methodes portant sur une therapie photodynamique ciblee
WO2006124748A3 (fr) Composes polycycliques et procedes pour les utiliser
WO2005019258A3 (fr) Compositions et methodes de traitement de maladies relatives au systeme immunitaire
WO2003101397A3 (fr) Vaccins tetravalents contre la dengue
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2006013441A3 (fr) Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau
WO2004080418A3 (fr) Composes d'acide nucleique pouvant inhiber l'angiogenese et la croissance tumorale
WO2004080391A3 (fr) Nouveaux agents antibacteriens
WO2006128041A3 (fr) Compositions et procedes destines a traiter ou a prevenir un neoplasme chimiomoresistant
WO2005118592A8 (fr) Tetrahydropyridothiophenes utilises dans le traitement anticancereux
WO2003045230A3 (fr) Compositions et procedes contre le cancer
EP1667685A4 (fr) Inhibiteurs du canal potassique a base de quinazoline
WO2003057146A3 (fr) Compositions et procedes concernant le cancer
WO2003102185A3 (fr) Procedes et compositions pour traiter une neoplasie associee aux molecules d'acides nucleiques de a1 et a2 de hnrnp
WO2003053224A3 (fr) Nouvelles compositions et methodes contre le cancer
WO2005077397A3 (fr) Procedes et compositions pour le traitement de maladies vasculaires
GB0324656D0 (en) A protein involved in ovarian cancer
WO2003087840A3 (fr) Proteine intervenant dans le cancer
WO2006043060A3 (fr) Proteine contenant le domaine mam

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase